Global and China Heparin Market Insights, Forecast to 2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 145
Inquire Before Buying

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Global Heparin key players include Hepalink, Bioibérica, Pfizer, King-friend Biochemical Pharmaceutical, Jiulong Biochemicals, etc. Global top five manufacturers hold a share about 55%. Europe is the largest market, with a share about 40%, followed by USA, with a share about 35 percent. In terms of product, Heparin Sodium is the largest segment, with a share about 90%. And in terms of application, the largest application is LMWH, followed by UFH.

Market Analysis and Insights: Global and China Heparin Market

This report focuses on global and China Heparin market.

In 2020, the global Heparin market size was US$ 1087 million and it is expected to reach US$ 1332.1 million by the end of 2027, with a CAGR of 3.4% during 2021-2027. In China the Heparin market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Heparin Scope and Market Size

Heparin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Heparin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Heparin Sodium

- Heparin Calcium

- Other

Segment by Application

- UFH

- LMWH

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Hepalink

- Changshan Pharm

- Qianhong Bio-pharma

- Opocrin

- Pfizer

- Aspen Oss

- King-friend Biochemical Pharmaceutical

- Bioibérica

- Dongcheng Biochemicals

- Jiulong Biochemicals

- Tiandong

- Xinbai

- Yino Pharma

- Deebio

Global and China Heparin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Heparin Market Size Growth Rate by Type
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.2.4 Other
1.3 Market by Application
1.3.1 Global Heparin Market Size Growth Rate by Application
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Heparin Market Size, Estimates and Forecasts
2.1.1 Global Heparin Revenue 2016-2027
2.1.2 Global Heparin Sales 2016-2027
2.2 Global Heparin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Heparin Historical Market Size by Region (2016-2021)
2.3.1 Global Heparin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Heparin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Heparin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Heparin Sales Forecast by Region (2022-2027)
2.4.2 Global Heparin Revenue Forecast by Region (2022-2027)
3 Global Heparin Competitor Landscape by Players
3.1 Global Top Heparin Manufacturers by Sales
3.1.1 Global Heparin Sales by Manufacturer (2016-2021)
3.1.2 Global Heparin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Heparin Manufacturers by Revenue
3.2.1 Key Heparin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Heparin Revenue by Manufacturers (2016-2021)
3.2.3 Global Heparin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Heparin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Heparin Revenue in 2020
3.2.6 Global Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Heparin Price by Manufacturers
3.4 Global Heparin Manufacturing Base Distribution, Product Types
3.4.1 Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Heparin Product Type
3.4.3 Date of International Manufacturers Enter into Heparin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Heparin Market Size by Type (2016-2021)
4.1.1 Global Heparin Sales by Type (2016-2021)
4.1.2 Global Heparin Revenue by Type (2016-2021)
4.1.3 Heparin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Heparin Market Size Forecast by Type (2022-2027)
4.2.1 Global Heparin Sales Forecast by Type (2022-2027)
4.2.2 Global Heparin Revenue Forecast by Type (2022-2027)
4.2.3 Heparin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Heparin Market Size by Application (2016-2021)
5.1.1 Global Heparin Sales by Application (2016-2021)
5.1.2 Global Heparin Revenue by Application (2016-2021)
5.1.3 Heparin Price by Application (2016-2021)
5.2 Heparin Market Size Forecast by Application (2022-2027)
5.2.1 Global Heparin Sales Forecast by Application (2022-2027)
5.2.2 Global Heparin Revenue Forecast by Application (2022-2027)
5.2.3 Global Heparin Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Heparin Market Size YoY Growth 2016-2027
6.1.1 China Heparin Sales YoY Growth 2016-2027
6.1.2 China Heparin Revenue YoY Growth 2016-2027
6.1.3 China Heparin Market Share in Global Market 2016-2027
6.2 China Heparin Market Size by Players (International and Local Players)
6.2.1 China Top Heparin Players by Sales (2016-2021)
6.2.2 China Top Heparin Players by Revenue (2016-2021)
6.3 China Heparin Historic Market Review by Type (2016-2021)
6.3.1 China Heparin Sales Market Share by Type (2016-2021)
6.3.2 China Heparin Revenue Market Share by Type (2016-2021)
6.3.3 China Heparin Price by Type (2016-2021)
6.4 China Heparin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Heparin Sales Forecast by Type (2022-2027)
6.4.2 China Heparin Revenue Forecast by Type (2022-2027)
6.4.3 China Heparin Price Forecast by Type (2022-2027)
6.5 China Heparin Historic Market Review by Application (2016-2021)
6.5.1 China Heparin Sales Market Share by Application (2016-2021)
6.5.2 China Heparin Revenue Market Share by Application (2016-2021)
6.5.3 China Heparin Price by Application (2016-2021)
6.6 China Heparin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Heparin Sales Forecast by Application (2022-2027)
6.6.2 China Heparin Revenue Forecast by Application (2022-2027)
6.6.3 China Heparin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Heparin Market Size YoY Growth 2016-2027
7.2 North America Heparin Market Facts & Figures by Country
7.2.1 North America Heparin Sales by Country (2016-2021)
7.2.2 North America Heparin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Heparin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Heparin Market Facts & Figures by Region
8.2.1 Asia Pacific Heparin Sales by Region (2016-2021)
8.2.2 Asia Pacific Heparin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Heparin Market Size YoY Growth 2016-2027
9.2 Europe Heparin Market Facts & Figures by Country
9.2.1 Europe Heparin Sales by Country (2016-2021)
9.2.2 Europe Heparin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Heparin Market Size YoY Growth 2016-2027
10.2 Latin America Heparin Market Facts & Figures by Country
10.2.1 Latin America Heparin Sales by Country (2016-2021)
10.2.2 Latin America Heparin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Heparin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Heparin Market Facts & Figures by Country
11.2.1 Middle East and Africa Heparin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Heparin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Hepalink
12.1.1 Hepalink Corporation Information
12.1.2 Hepalink Description and Business Overview
12.1.3 Hepalink Heparin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hepalink Heparin Products Offered
12.1.5 Hepalink Recent Development
12.2 Changshan Pharm
12.2.1 Changshan Pharm Corporation Information
12.2.2 Changshan Pharm Description and Business Overview
12.2.3 Changshan Pharm Heparin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Changshan Pharm Heparin Products Offered
12.2.5 Changshan Pharm Recent Development
12.3 Qianhong Bio-pharma
12.3.1 Qianhong Bio-pharma Corporation Information
12.3.2 Qianhong Bio-pharma Description and Business Overview
12.3.3 Qianhong Bio-pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Qianhong Bio-pharma Heparin Products Offered
12.3.5 Qianhong Bio-pharma Recent Development
12.4 Opocrin
12.4.1 Opocrin Corporation Information
12.4.2 Opocrin Description and Business Overview
12.4.3 Opocrin Heparin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Opocrin Heparin Products Offered
12.4.5 Opocrin Recent Development
12.5 Pfizer
12.5.1 Pfizer Corporation Information
12.5.2 Pfizer Description and Business Overview
12.5.3 Pfizer Heparin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Pfizer Heparin Products Offered
12.5.5 Pfizer Recent Development
12.6 Aspen Oss
12.6.1 Aspen Oss Corporation Information
12.6.2 Aspen Oss Description and Business Overview
12.6.3 Aspen Oss Heparin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Aspen Oss Heparin Products Offered
12.6.5 Aspen Oss Recent Development
12.7 King-friend Biochemical Pharmaceutical
12.7.1 King-friend Biochemical Pharmaceutical Corporation Information
12.7.2 King-friend Biochemical Pharmaceutical Description and Business Overview
12.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 King-friend Biochemical Pharmaceutical Heparin Products Offered
12.7.5 King-friend Biochemical Pharmaceutical Recent Development
12.8 Bioibérica
12.8.1 Bioibérica Corporation Information
12.8.2 Bioibérica Description and Business Overview
12.8.3 Bioibérica Heparin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bioibérica Heparin Products Offered
12.8.5 Bioibérica Recent Development
12.9 Dongcheng Biochemicals
12.9.1 Dongcheng Biochemicals Corporation Information
12.9.2 Dongcheng Biochemicals Description and Business Overview
12.9.3 Dongcheng Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Dongcheng Biochemicals Heparin Products Offered
12.9.5 Dongcheng Biochemicals Recent Development
12.10 Jiulong Biochemicals
12.10.1 Jiulong Biochemicals Corporation Information
12.10.2 Jiulong Biochemicals Description and Business Overview
12.10.3 Jiulong Biochemicals Heparin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jiulong Biochemicals Heparin Products Offered
12.10.5 Jiulong Biochemicals Recent Development
12.11 Hepalink
12.11.1 Hepalink Corporation Information
12.11.2 Hepalink Description and Business Overview
12.11.3 Hepalink Heparin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hepalink Heparin Products Offered
12.11.5 Hepalink Recent Development
12.12 Xinbai
12.12.1 Xinbai Corporation Information
12.12.2 Xinbai Description and Business Overview
12.12.3 Xinbai Heparin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Xinbai Products Offered
12.12.5 Xinbai Recent Development
12.13 Yino Pharma
12.13.1 Yino Pharma Corporation Information
12.13.2 Yino Pharma Description and Business Overview
12.13.3 Yino Pharma Heparin Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Yino Pharma Products Offered
12.13.5 Yino Pharma Recent Development
12.14 Deebio
12.14.1 Deebio Corporation Information
12.14.2 Deebio Description and Business Overview
12.14.3 Deebio Heparin Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Deebio Products Offered
12.14.5 Deebio Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Heparin Industry Trends
13.2 Heparin Market Drivers
13.3 Heparin Market Challenges
13.4 Heparin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Heparin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Heparin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Heparin Sodium
Table 3. Major Manufacturers of Heparin Calcium
Table 4. Major Manufacturers of Other
Table 5. Global Heparin Market Size Growth Rate by Application (2021-2027) & (B Units)
Table 6. Global Heparin Market Size by Region (B Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Heparin Sales by Regions (2016-2021) & (B Units)
Table 8. Global Heparin Sales Market Share by Regions (2016-2021)
Table 9. Global Heparin Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Heparin Sales Forecast by Region (2022-2027) & (B Units)
Table 11. Global Heparin Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Heparin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Heparin Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Heparin Sales by Manufacturers (2016-2021) (B Units)
Table 15. Global Heparin Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Heparin Manufacturers by Revenue (US$ Million) in 2020
Table 17. Heparin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Heparin Revenue Share by Manufacturers (2016-2021)
Table 19. Global Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heparin as of 2020)
Table 21. Key Manufacturers Heparin Price (2016-2021) (USD/Unit)
Table 22. Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Heparin Product Type
Table 24. Date of International Manufacturers Enter into Heparin Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Heparin Sales by Type (2016-2021) (B Units)
Table 27. Global Heparin Sales Share by Type (2016-2021)
Table 28. Global Heparin Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Heparin Revenue Share by Type (2016-2021)
Table 30. Heparin Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Heparin Sales Forecast by Type (2022-2027) & (B Units)
Table 32. Global Heparin Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Heparin Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Heparin Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Heparin Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Heparin Sales by Application (2016-2021) (B Units)
Table 37. Global Heparin Sales Share by Application (2016-2021)
Table 38. Global Heparin Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Heparin Revenue Share by Application (2016-2021)
Table 40. Heparin Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Heparin Sales Forecast by Application (2022-2027) & (B Units)
Table 42. Global Heparin Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Heparin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Heparin Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Heparin Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. China Heparin Sales (B Units) of Key Companies (2016-2021)
Table 47. China Heparin Sales Share by Company (2016-2021)
Table 48. China Heparin Revenue (US$ Million) by Company (2016-2021)
Table 49. China Heparin Revenue Share by Company (2016-2021)
Table 50. China Heparin Sales (B Units) by Type (2016-2021)
Table 51. China Heparin Sales Share by Type (2016-2021)
Table 52. China Heparin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Heparin Price (USD/Unit) by Type (2016-2021)
Table 54. China Heparin Sales (B Units) by Type (2022-2027)
Table 55. China Heparin Sales Share by Type (2022-2027)
Table 56. China Heparin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Heparin Revenue Share by Type (2022-2027)
Table 58. China Heparin Price (USD/Unit) by Type (2022-2027)
Table 59. China Heparin Sales (B Units) by Application (2016-2021)
Table 60. China Heparin Sales Share by Application (2016-2021)
Table 61. China Heparin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Heparin Price (USD/Unit) by Application (2016-2021)
Table 63. China Heparin Sales (B Units) by Application (2022-2027)
Table 64. China Heparin Sales Share by Application (2022-2027)
Table 65. China Heparin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Heparin Revenue Share by Application (2022-2027)
Table 67. China Heparin Price (USD/Unit) by Application (2022-2027)
Table 68. North America Heparin Sales by Country (2016-2021) & (B Units)
Table 69. North America Heparin Sales Market Share by Country (2016-2021)
Table 70. North America Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Heparin Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Heparin Sales by Region (2016-2021) & (B Units)
Table 73. Asia Pacific Heparin Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Heparin Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Heparin Revenue Market Share by Region (2016-2021)
Table 76. Europe Heparin Sales by Country (2016-2021) & (B Units)
Table 77. Europe Heparin Sales Market Share by Country (2016-2021)
Table 78. Europe Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Heparin Revenue Market Share by Country (2016-2021)
Table 80. Latin America Heparin Sales by Country (2016-2021) & (B Units)
Table 81. Latin America Heparin Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Heparin Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Heparin Sales by Country (2016-2021) & (B Units)
Table 85. Middle East and Africa Heparin Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Heparin Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Heparin Revenue Market Share by Country (2016-2021)
Table 88. Hepalink Corporation Information
Table 89. Hepalink Description and Business Overview
Table 90. Hepalink Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Hepalink Heparin Product
Table 92. Hepalink Recent Development
Table 93. Changshan Pharm Corporation Information
Table 94. Changshan Pharm Description and Business Overview
Table 95. Changshan Pharm Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Changshan Pharm Product
Table 97. Changshan Pharm Recent Development
Table 98. Qianhong Bio-pharma Corporation Information
Table 99. Qianhong Bio-pharma Description and Business Overview
Table 100. Qianhong Bio-pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Qianhong Bio-pharma Product
Table 102. Qianhong Bio-pharma Recent Development
Table 103. Opocrin Corporation Information
Table 104. Opocrin Description and Business Overview
Table 105. Opocrin Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Opocrin Product
Table 107. Opocrin Recent Development
Table 108. Pfizer Corporation Information
Table 109. Pfizer Description and Business Overview
Table 110. Pfizer Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Pfizer Product
Table 112. Pfizer Recent Development
Table 113. Aspen Oss Corporation Information
Table 114. Aspen Oss Description and Business Overview
Table 115. Aspen Oss Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Aspen Oss Product
Table 117. Aspen Oss Recent Development
Table 118. King-friend Biochemical Pharmaceutical Corporation Information
Table 119. King-friend Biochemical Pharmaceutical Description and Business Overview
Table 120. King-friend Biochemical Pharmaceutical Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. King-friend Biochemical Pharmaceutical Product
Table 122. King-friend Biochemical Pharmaceutical Recent Development
Table 123. Bioibérica Corporation Information
Table 124. Bioibérica Description and Business Overview
Table 125. Bioibérica Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Bioibérica Product
Table 127. Bioibérica Recent Development
Table 128. Dongcheng Biochemicals Corporation Information
Table 129. Dongcheng Biochemicals Description and Business Overview
Table 130. Dongcheng Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Dongcheng Biochemicals Product
Table 132. Dongcheng Biochemicals Recent Development
Table 133. Jiulong Biochemicals Corporation Information
Table 134. Jiulong Biochemicals Description and Business Overview
Table 135. Jiulong Biochemicals Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Jiulong Biochemicals Product
Table 137. Jiulong Biochemicals Recent Development
Table 138. Tiandong Corporation Information
Table 139. Tiandong Description and Business Overview
Table 140. Tiandong Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Tiandong Product
Table 142. Tiandong Recent Development
Table 143. Xinbai Corporation Information
Table 144. Xinbai Description and Business Overview
Table 145. Xinbai Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Xinbai Product
Table 147. Xinbai Recent Development
Table 148. Yino Pharma Corporation Information
Table 149. Yino Pharma Description and Business Overview
Table 150. Yino Pharma Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Yino Pharma Product
Table 152. Yino Pharma Recent Development
Table 153. Deebio Corporation Information
Table 154. Deebio Description and Business Overview
Table 155. Deebio Heparin Sales (B Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Deebio Product
Table 157. Deebio Recent Development
Table 158. Heparin Market Trends
Table 159. Heparin Market Drivers
Table 160. Heparin Market Challenges
Table 161. Heparin Market Restraints
Table 162. Heparin Customers List
Table 163. Heparin Distributors List
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Heparin Product Picture
Figure 2. Global Heparin Sales Market Share by Type in 2020 & 2027
Figure 3. Heparin Sodium Product Picture
Figure 4. Heparin Calcium Product Picture
Figure 5. Other Product Picture
Figure 6. Global Heparin Sales Market Share by Application in 2020 & 2027
Figure 7. UFH
Figure 8. LMWH
Figure 9. Heparin Report Years Considered
Figure 10. Global Heparin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Heparin Market Size 2016-2027 (US$ Million)
Figure 12. Global Heparin Sales 2016-2027 (B Units)
Figure 13. Global Heparin Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Heparin Sales Market Share by Region (2016-2021)
Figure 15. Global Heparin Sales Market Share by Region in 2020
Figure 16. Global Heparin Revenue Market Share by Region (2016-2021)
Figure 17. Global Heparin Revenue Market Share by Region in 2020
Figure 18. Global Heparin Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Heparin Revenue in 2020
Figure 20. Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Heparin Sales Market Share by Type (2016-2021)
Figure 22. Global Heparin Sales Market Share by Type in 2020
Figure 23. Global Heparin Revenue Market Share by Type (2016-2021)
Figure 24. Global Heparin Revenue Market Share by Type in 2020
Figure 25. Global Heparin Sales Market Share by Application (2016-2021)
Figure 26. Global Heparin Sales Market Share by Application in 2020
Figure 27. Global Heparin Revenue Market Share by Application (2016-2021)
Figure 28. Global Heparin Revenue Market Share by Application in 2020
Figure 29. China Heparin Sales Growth Rate 2016-2027 (B Units)
Figure 30. China Heparin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Heparin Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Heparin Players Market Share by Revenue in Heparin in 2020
Figure 33. China Heparin Revenue Share by Type (2016-2021)
Figure 34. China Heparin Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Heparin Revenue Share by Application (2016-2021)
Figure 36. China Heparin Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Heparin Sales Growth Rate 2016-2021 (B Units)
Figure 38. North America Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Heparin Sales Market Share by Country in 2020
Figure 40. North America Heparin Revenue Market Share by Country in 2020
Figure 41. U.S. Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 42. U.S. Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 44. Canada Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Heparin Sales Growth Rate 2016-2021 (B Units)
Figure 46. Europe Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Heparin Sales Market Share by Country in 2020
Figure 48. Europe Heparin Revenue Market Share by Country in 2020
Figure 49. Germany Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 50. Germany Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 52. France Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 54. U.K. Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 56. Italy Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 58. Russia Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Heparin Sales Growth Rate 2016-2021 (B Units)
Figure 60. Asia Pacific Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Heparin Sales Market Share by Region in 2020
Figure 62. Asia Pacific Heparin Revenue Market Share by Region in 2020
Figure 63. China Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 64. China Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 66. Japan Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 68. South Korea Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 70. India Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 72. Australia Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 74. Taiwan Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 76. Indonesia Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 78. Thailand Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 80. Malaysia Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 82. Philippines Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 84. Vietnam Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Heparin Sales Growth Rate 2016-2021 (B Units)
Figure 86. Latin America Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Heparin Sales Market Share by Country in 2020
Figure 88. Latin America Heparin Revenue Market Share by Country in 2020
Figure 89. Mexico Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 90. Mexico Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 92. Brazil Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 94. Argentina Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Heparin Sales Growth Rate 2016-2021 (B Units)
Figure 96. Middle East and Africa Heparin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Heparin Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Heparin Revenue Market Share by Country in 2020
Figure 99. Turkey Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 100. Turkey Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 102. Saudi Arabia Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. U.A.E Heparin Sales Growth Rate (2016-2021) (B Units)
Figure 104. U.A.E Heparin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Heparin Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
  • Global and Japan Hemophilia A Drug Market Insights, Forecast to 2027
    Published: 17-Sep-2021        Price: US 3900 Onwards        Pages: 157
    Hemophilia A Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia A Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Hemophilia A Drug mar......
  • United States Injectable Anticoagulants Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Injectable Anticoagulants Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Injectable Anticoagulants Market Segment Percentages, By Type, 2020 (%) - Low-Molecular-Weight Heparin (LMWH) - Direct Thrombin Inhibitor (DTI) - Others United States Injectable Anticoagulants Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Injectable Anticoagulants Market Segment Percentages, By Application, 2020 (%)......
  • United States Intravenous Immunoglobulin (IVIg) Market Report & Forecast 2021-2027
    Published: 17-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Intravenous Immunoglobulin (IVIg) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Bottle) United States Intravenous Immunoglobulin (IVIg) Market Segment Percentages, By Type, 2020 (%) - IVIg Liquid - IVIg Powder United States Intravenous Immunoglobulin (IVIg) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Bottle) United States Intravenous Immunoglobulin (IVIg) Market Segment Percentages, By Application, 2020 (%)......
  • United States Heparin Market Report & Forecast 2021-2027
    Published: 16-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Heparin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (B Units) United States Heparin Market Segment Percentages, By Type, 2020 (%) - Heparin Sodium - Heparin Calcium - Other United States Heparin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (B Units) United States Heparin Market Segment Percentages, By Application, 2020 (%) - UFH - LMWH Competitor Analysis The report also pr......
  • United States Heparin Sodium Market Report & Forecast 2021-2027
    Published: 16-Sep-2021        Price: US 3400 Onwards        Pages: 109
    United States Heparin Sodium Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Heparin Sodium Market Segment Percentages, By Type, 2020 (%) - Oral Type - Injection Type United States Heparin Sodium Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Heparin Sodium Market Segment Percentages, By Application, 2020 (%) - Treatment of Venous Thromboembolism - Complications of Pregnancy - ......
  • United States Fibrinogen Concentrate Market Report & Forecast 2021-2027
    Published: 14-Sep-2021        Price: US 3400 Onwards        Pages: 92
    United States Fibrinogen Concentrate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Fibrinogen Concentrate Market Segment Percentages, By Type, 2020 (%) - Human Fibrinogen Concentrate - Others United States Fibrinogen Concentrate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg) United States Fibrinogen Concentrate Market Segment Percentages, By Application, 2020 (%) - Surgical Procedures - Congenita......
  • Global and China Factor IX Deficiency Treatment Market Size, Status and Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3900 Onwards        Pages: 95
    Global Factor IX Deficiency Treatment Scope and Market Size Factor IX Deficiency Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Factor IX Deficiency Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.......
  • Global and China Heparin Sodium Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 157
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by ......
  • Global and China Heparin Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 145
    Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API). Glob......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs